Analysis of stimulant prescriptions and drug-related poisoning risk among persons receiving buprenorphine treatment for opioid use disorder

Authors

Carrie M Mintz, Washington University School of Medicine in St. Louis
Kevin Y Xu, Washington University School of Medicine in St. Louis
Ned J Presnall, Washington University in St Louis
Sarah M Hartz, Washington University School of Medicine in St. Louis
Frances R Levin, Columbia University
Jeffrey F Scherrer, Saint Louis University
Laura J Bierut, Washington University School of Medicine in St. Louis
Richard A Grucza, Saint Louis University

Journal

JAMA Network Open

Publication Date

5-2-2022

Volume

5

Issue

5

First Page

e2211634

Document Type

Open Access Publication

DOI

10.1001/jamanetworkopen.2022.11634

Rights and Permissions

Mintz CM, Xu KY, Presnall NJ, Hartz SM, Levin FR, Scherrer JF, Bierut LJ, Grucza RA. Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder. JAMA Netw Open. 2022 May 2;5(5):e2211634. doi: 10.1001/jamanetworkopen.2022.11634. This is an open access article distributed under the terms of the CC-BY License.

Recommended Citation

Mintz, Carrie M; Xu, Kevin Y; Presnall, Ned J; Hartz, Sarah M; Levin, Frances R; Scherrer, Jeffrey F; Bierut, Laura J; and Grucza, Richard A, "Analysis of stimulant prescriptions and drug-related poisoning risk among persons receiving buprenorphine treatment for opioid use disorder." JAMA Network Open. 5, 5. e2211634 (2022).
https://digitalcommons.wustl.edu/oa_4/543